Urodynamic Equipment and Consumables Market

Urodynamic Equipment and Consumables Market Size

The global urodynamic equipment and consumables market was valued at USD 366.7 million in 2024. The market is expected to reach from USD 385.9 million in 2025 to USD 704.5 million in 2034, growing at a CAGR of 6.9% during the forecast period, according to the latest report published by Global Market Insights Inc. The high market growth is attributed to the technological advancements in urodynamic devices, rising prevalence of urological disorders, rising awareness and early diagnosis, and expansion of outpatient and ambulatory care centers, among other contributing factors.

Urodynamic equipment and consumables are medical devices and associated materials used to assess the function of the lower urinary tract. These devices allow measuring bladder pressure, urine flow, and sphincter activity, etc. in order to find the cause of urinary disorders. Consumables are such items as catheters, sensors, and tubing necessary for performing urodynamic tests.

Leading players in the urodynamic equipment and consumables market include Laborie, Albyn Medical (CREO MEDICAL), The Prometheus Group, SRS Medical, MEDKONSULT medical technology, and CooperSurgical. These companies maintain their competitive edge through continuous product innovation, global market presence, and significant investments in research and development.

The market has increased from USD 312.9 million in 2021 and reached USD 347.6 million in 2023, with the historic growth rate of 5.4%. The market growth was driven by the rising prevalence of urological disorders such as urinary incontinence and neurogenic bladder, growing awareness regarding urodynamic diagnostics, technological advancements in diagnostic equipment, and increasing adoption of minimally invasive and precise diagnostic procedures across hospitals and diagnostic centers.

Moreover, the rising prevalence of urinary incontinence, overactive bladder, prostate enlargement, and neurogenic bladder drives the demand for urodynamic testing. For instance, according to the National Institutes of Health (NIH), urinary incontinence affects approximately 25 million adults in the U.S. in 2023, with nearly 33% of people aged 65 and above experiencing this condition.

The World Health Organization (WHO) reported that benign prostatic hyperplasia affects about 40% of men in their 50s and 80% of men in their 70s in 2022. The accurate diagnosis provided by urodynamic equipment enables physicians to develop specific treatment plans, increasing market adoption. The growing elderly population in developed regions, which the United Nations estimates will reach 1.6 billion by 2024, further strengthens this demand.

Furthermore, innovations such as wireless catheters, multi-channel pressure systems, portable urodynamic devices, and software-based diagnostic solutions enhance accuracy, ease of use, and patient comfort. These improvements encourage healthcare providers to upgrade existing systems, contributing to market growth.

Urodynamic Equipment and Consumables Market Trends

The urodynamic equipment and consumables industry is growing considerably with the shift towards minimally invasive and wireless devices, integration with digital health and software solutions, rising adoption in emerging markets, and growth in home-based and ambulatory testing, among other factors collectively driving industry growth.

• Manufacturers are developing portable, wireless, and catheter-free urodynamic systems that reduce patient discomfort. These devices enable real-time data collection, improve workflow efficiency, and are increasingly preferred in outpatient and home-care settings.
  
• Advanced urodynamic equipment now includes software for data analysis, cloud storage, and remote monitoring. Integration with electronic health records (EHRs) and AI-driven analytics enhances diagnostic accuracy and supports personalized treatment planning.
  
• Healthcare infrastructure improvements, rising awareness of urinary disorders, and growing affordability of diagnostic equipment are driving adoption in regions such as Asia Pacific and Latin America. Companies are strategically targeting these markets with cost-effective and portable solutions.
  
• Additionally, portable urodynamic systems suitable for home or ambulatory care are becoming more popular. This trend aligns with the rise of telemedicine and outpatient services, allowing patients to undergo testing without hospital admission and, thereby supporting sustained market growth.
  

Urodynamic Equipment and Consumables Market Analysis

The global market was valued at USD 312.9 million in 2021. The market size reached USD 347.6 million in 2023, from USD 329.7 million in 2022.

Based on the product type, the urodynamic equipment and consumables market is segmented into equipment and consumables. The equipment segment has asserted its dominance in the market by securing a significant market share of 66.9% in 2024 owing to the rising prevalence of urological disorders, increasing adoption of advanced diagnostic technologies, and the growing demand for accurate and comprehensive urodynamic assessments in hospitals and specialized clinics. The segment is expected to exceed USD 462.9 million by 2034, growing at a CAGR of 6.7% during the forecast period.

On the other hand, the consumables segment is expected to grow with a CAGR of 7.3%. The growth of this segment is driven by the recurring demand for single-use catheters, transducer sets, and other disposable accessories, rising adoption of minimally invasive urodynamic procedures, and increasing awareness of infection - control protocols in hospitals and outpatient settings.

• The equipment segment continues to dominate the market. The increasing elderly population, who are more susceptible to urinary dysfunctions, drives the demand for advanced diagnostic equipment. According to the World Health Organization (WHO), the global population aged 60 years and above was reached 1.4 billion by 2023, up from 1 billion in 2021.
  
• In addition, the United Nations estimates that by 2024, approximately 28.9% of Europe's population will be aged 60 or older. These diagnostic tools enable detailed assessments for improved patient management, particularly in geriatric care facilities, where urinary dysfunction affects 15-30% of people aged 65 and above, as reported by the National Institutes of Health in 2023.
  
• Moreover, portable and easy-to-use urodynamic equipment is highly preferred in outpatient clinics and ambulatory surgical centers. This trend allows efficient diagnostics without hospital admission, driving the demand for compact and advanced devices.
  
• The consumables segment held a revenue of USD 121.4 million in 2024, with projections indicating a steady expansion at 7.3% CAGR from 2025 to 2034. The segment is driven by the recurring need for disposable items such as catheters, transducer sets, and tubing, which are essential for each urodynamic test. Increasing adoption of minimally invasive and outpatient procedures has further boosted demand for single-use consumables.
  
• Additionally, stringent infection-control protocols in hospitals and clinics are encouraging the use of disposable equipment to prevent cross-contamination. Rising awareness of urological disorders and the expansion of diagnostic services in emerging markets are also supporting sustained growth in this segment.
  

Based on end use, the urodynamic equipment and consumables market is classified into hospitals, urology clinics, ambulatory surgical centers, and other end users. The hospitals segment dominated the market with a revenue share of 52.9% in 2024 and is expected to reach USD 364.9 million within the forecast period.

• Hospitals are increasing urology departments to satisfy growing patient demands for diagnosis and treatment of urinary disorders. The provision of comprehensive urodynamic testing not only attracts more patients but also broadens the hospital’s service portfolio, thus promoting the use of equipment and consumables.
  
• Moreover, hospitals are focusing on precise diagnosis and tailored treatment to obtain positive patient outcomes. A decision to purchase sophisticated urodynamic systems will be instrumental in achieving early detection of disorders, lowering the risk of complications, and improves overall care quality.
  
• The urology clinics segment accounted for significant revenue in 2024, with projections indicating a steady expansion at 7.1% CAGR from 2025 to 2034. The segment's expansion is mainly due to the increased adoption of diagnostic procedures for urinary disorders, supported by the presence of trained staff and state-of-the-art equipment. The patient influx for outpatient and minimally invasive urodynamic testing is on the rise, which is boosting the demand for equipment and consumables in these settings.
  
• The ambulatory surgical centers segment held a revenue of USD 50.7 million in 2024, with projections indicating a steady expansion at 7.5% CAGR from 2025 to 2034. The segmental growth is driven by adopting portable and efficient urodynamic systems that enable quick and accurate diagnostics in outpatient settings. The rising preference for minimally invasive procedures and same-day treatments increases the demand for both equipment and disposable consumables in ASCs.
  

North America Urodynamic Equipment and Consumables Market

North America dominated the global urodynamic equipment and consumables industry with the highest market share of 45.4% in 2024.

• The U.S. market was valued at USD 134.9 million and USD 141.7 million in 2021 and 2022, respectively. The market size reached USD 156.5 million in 2024, growing from USD 148.9 million in 2023, and is anticipated to grow at a CAGR of 6.5% between 2025 to 2034.
  
• North America has a significant patient population affected by urinary incontinence, overactive bladder, and prostate-related disorders. The growing awareness for accurate diagnosis has become a major factor in hospitals and clinics installing advanced urodynamic systems and consumables.
  
• In the U.S. and Canada, the insurance coverage and the support from Medicare/Medicaid for urodynamic tests make the cost for patients relatively low. Thus, the patients are encouraged to undergo frequent testing which, in turn, motivates healthcare providers to obtain modern diagnostic equipment and consumables.
  
• Further, the region’s advanced healthcare infrastructure, including specialized urology centers and tertiary hospitals, supports the adoption of sophisticated urodynamic equipment. High-quality facilities are more likely to invest in cutting-edge technology to maintain clinical excellence.
  

Europe Urodynamic Equipment and Consumables Market

Europe market accounted for USD 93.3 million in 2024 and is anticipated to show lucrative growth over the forecast period.

• Europe experiences a growth of chronic urinary diseases, which include benign prostatic hyperplasia, urinary incontinence, and neurogenic bladder, most notably among the elderly population. The demand of accurate diagnosis and the continuous monitoring is leading to the use of sophisticated urodynamic instruments and consumables in hospitals and speciality clinics to improve the level of patient care.
  
• Furthermore, there is an increasing preference for minimally invasive procedures in European healthcare, driven by patient comfort and reduced recovery times. Urodynamic devices with wireless, catheter-free, or portable features are being increasingly adopted in hospitals and outpatient settings, aligning with this trend.
  

Asia Pacific Urodynamic Equipment and Consumables Market

The Asia Pacific market is anticipated to grow at the highest CAGR of 7.8% during the analysis timeframe.

• Several countries in Asia Pacific, including China, India, and South Korea, are investing heavily in healthcare infrastructure. The expansion of hospitals, specialized urology centers, and diagnostic facilities has increased accessibility to advanced urodynamic equipment, driving market growth across the region.
  
• Governments and private healthcare providers are promoting awareness campaigns and early diagnostic screening programs for urinary disorders. Rising patient knowledge about the benefits of timely diagnosis encourages hospitals to invest in urodynamic equipment and consumables.
  

Latin America Urodynamic Equipment and Consumables Market

The Latin America urodynamic equipment and consumables industry is experiencing robust growth over the analysis timeframe.

• In Latin America, the market is being driven by expanding healthcare infrastructure and modernization of diagnostic facilities across major countries like Brazil and Mexico. Rising awareness of urological disorders among the population, coupled with increasing government initiatives for urinary incontinence management, is boosting market adoption. The growing number of specialized urology clinics and outpatient centers is further fuelling demand for both equipment and consumables.
  
• Additionally, improving affordability of advanced diagnostic devices and the gradual increase in health insurance coverage are encouraging more patients to seek urodynamic testing. The region is also witnessing interest from international manufacturers, who are introducing cost-effective and portable solutions tailored to local needs.
  

Middle East & Africa Urodynamic Equipment and Consumables Market

The Middle East & Africa (MEA) market is experiencing robust growth over the analysis timeframe.

• The regional growth is driven by rapid development of healthcare infrastructure and investment in speciality urology centers. Increasing government initiatives to improve diagnostic capabilities and rising awareness of urinary disorders among patients are boosting market adoption.
  
• The growing prevalence of lifestyle-related urological conditions is creating additional demand for advanced diagnostic solutions. Furthermore, the entry of international manufacturers offering region-specific, cost-effective, and portable systems is supporting market growth across both urban and semi-urban areas.
  

Urodynamic Equipment and Consumables Market Share

The global urodynamic equipment and consumables industry is highly competitive, characterized by the presence of both global and regional players focusing on innovation, product differentiation, and strategic collaborations. Companies are continuously investing in research and development to introduce advanced, portable, and wireless urodynamic systems, along with improved consumables, to enhance diagnostic accuracy and patient comfort.

Key players include Laborie, Albyn Medical (CREO MEDICAL), The Prometheus Group, SRS Medical, MEDKONSULT medical technology, and CooperSurgical, collectively accounting for 48% of the total market share.

Market competition is further intensified by factors such as pricing strategies, after-sales service, and regional expansion efforts. Firms are targeting emerging markets with cost-effective and user-friendly solutions to capture growing demand, while also strengthening their position in developed regions through technological advancements and comprehensive service networks.

Strategic partnerships, acquisitions, and product portfolio expansions remain critical approaches for players aiming to maintain and increase their market presence in this rapidly evolving landscape.

Urodynamic Equipment and Consumables Market Companies

A few of the prominent players operating in the urodynamic equipment and consumables industry include:

• Advin
• Albyn Medical (CREO MEDICAL)
• Ashlar Medical
• COOK MEDICAL
• CooperSurgical
• Digitimer
• HC Italia
• Laborie
• Medica
• MEDKONSULT medical technology
• Neomedix Systems
• Santron Meditronic
• SRS Medical
• The Prometheus Group
• Tic Medizintechnik
  
• Laborie

Laborie leads the urodynamic equipment and consumables market with an estimated ~32% market share in 2024, driven by its comprehensive portfolio of advanced urodynamic systems featuring integrated software, wireless technology, and intuitive interfaces for precise diagnostics. The company’s strong global footprint, continuous innovation, and commitment to clinical education further reinforce its leadership in urological diagnostic solutions.

• Albyn Medical (CREO MEDICAL)

Albyn Medical stands out for its high-quality, customizable urodynamic systems and consumables designed to meet varied clinical needs. Its European manufacturing excellence and integration with CREO Medical’s technology strengthen its position in precision diagnostics.

• The Prometheus Group

The Prometheus Group differentiates itself through robust, user-friendly urodynamic and pelvic health diagnostic systems tailored for clinical efficiency. The company’s focus on modular designs and interoperability with electronic health systems (EHRs) enhances workflow and patient data management.

Urodynamic Equipment and Consumables Industry News

• In April 2025, Bright Uro announced that the FDA granted 510(k) clearance for the Glean Urodynamics System, enabling wireless, catheter-free ambulatory urodynamics. This approval is expected to enhance the company’s presence in the U.S. market and showcased innovation in patient-friendly diagnostics. It also supports growth in the urodynamic equipment and consumables market by promoting adoption of advanced, minimally invasive technologies.
  
• In November 2023, Laborie Medical Technologies Corp. (Laborie) announced a strategic equity investment in Bright Uro. This investment strengthened Laborie’s portfolio in innovative urodynamic solutions and expanded its technological capabilities. It also supports growth in the market by accelerating the development and adoption of advanced, patient-friendly diagnostic systems.
  

The urodynamic equipment and consumables market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product Type

• Equipment
  • Urodynamic system
    • Standard urodynamic systems
    • Video urodynamic systems
  • Uroflowmetry equipment
  • Cystometer
  • Electromyographs
• Consumables
  • Urodynamic catheters
  • Transducer sets
  • Urodynamic pumps
  • Other consumables

Market, By End Use

• Hospitals
• Urology clinics
• Ambulatory surgical centers
• Other end users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE